Overview

Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Status:
Completed
Trial end date:
2018-09-26
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and effectiveness of OC-01 Nasal Spray as compared to placebo on signs and symptoms of dry eye disease
Phase:
Phase 2
Details
Lead Sponsor:
Oyster Point Pharma, Inc.
Treatments:
Varenicline